TELA Bio, Inc. (TELA) Institutional Ownership

Ownership Summary

TELA Bio, Inc. (NASDAQ:TELA) is held by 42 institutional investors per 13F filings through December 2025.

• These investors collectively held 60.7% of TELA Bio's outstanding shares in December 2025, up from 52.1% in September 2025.
• They increased total shares held in TELA by 26.9% quarter over quarter, and investors in TELA Bio decreased 12.5% from a year ago.
• Activity in TELA broke down as 18 buyers, 9 sellers, and 15 unchanged among 42 total holders.
• The aggregate institutional position in TELA Bio amounted to 27.58Mn shares as of December 2025, up by 5.85Mn shares quarter on quarter, and up 405.99K shares year over year.
• Essex Woodlands Management, Inc. leads ownership in TELA with 7.71Mn shares as of December 31, 2025, equal to 16.98% of outstanding shares.
• The most significant purchases of TELA for the quarter ending December 2025 came from Essex Woodlands Management, Inc. (3.6Mn), UBS Group AG (1.28Mn), PERKINS CAPITAL MANAGEMENT INC (563.49K), Stonepine Capital Management, LLC (196.51K), Embree Financial Group (97.32K).
• Leading sellers of TELA Bio shares for the quarter ending December 2025 were SILVERARC CAPITAL MANAGEMENT, LLC (135.41K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (48.59K), GSA CAPITAL PARTNERS LLP (32.0K), CITADEL ADVISORS LLC (11.9K), Northern Trust Corp (921).
• TELA Bio's 10 largest shareholders as of December 2025 include Essex Woodlands Management, Inc. (7.71Mn), Nantahala Capital Management, LLC (5.11Mn), SILVERARC CAPITAL MANAGEMENT, LLC (2.65Mn), Stonepine Capital Management, LLC (2.35Mn), VANGUARD GROUP INC (1.83Mn), UBS Group AG (1.5Mn), DAFNA Capital Management LLC (1.44Mn), PERKINS CAPITAL MANAGEMENT INC (1.4Mn), Citigroup Inc (750.0K), Sio Capital Management, LLC (636.3K) per Business Quant data.